In the present study, activation of PKC by a sub-vasomotor concentration of PDBu elicits endothelial dysfunction by inhibiting endothelium-dependent, NO-mediated vasodilations (adenosine and serotonin) via elevated oxidative stress. The gene discussed is PRRT2; the disease is endothelial dysfunction.